Orforglipron, an oral non-peptide GLP-1 drug, helps women with obesity or overweight lose significantly more weight than placebo, regardless of menopausal stage.

Patients with inflammatory myopathies experience pain patterns ranging from localized disease-related discomfort to ...

In hospitals, registered nurses (RNs) monitor patients during rounds, respond to call lights, and check vital signs. But ...

Patients with treatment-resistant depression who are persistently unable to feel pleasure have higher risks for suicidal ...

Women with extramammary Paget disease (EMPD) showed a lower risk for cancer-specific and all-cause mortality compared with ...

Intrauterine mepivacaine reduces pain during IUD placement, while 1 in 5 patients choose moderate intravenous sedation when ...

Misuse of the HINTS exam remains common. A new review clarifies which patients with acute dizziness should — and should not — ...

International consensus advises screening at three points during childhood for early-stage T1D, if the necessary ...

New genome analysis suggests the Kent MenB strain picked up DNA from harmless throat bacteria, raising its virulence.

The FDA has approved the once-weekly injectable basal insulin drug insulin efsitora alfa-gobe (Onswik, Eli Lilly) for use as ...

The findings highlight how subtle verbal and nonverbal behaviors may shape patient trust in reassuring medical information.

Eczema affecting the head, neck, or hands in infancy is tied to higher risk for food allergy, with widespread eczema ...